Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001350891 | SCV001545318 | uncertain significance | Cohen syndrome | 2021-08-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002368151 | SCV002662363 | uncertain significance | Inborn genetic diseases | 2018-01-19 | criteria provided, single submitter | clinical testing | The p.T2353S variant (also known as c.7058C>G), located in coding exon 38 of the VPS13B gene, results from a C to G substitution at nucleotide position 7058. The threonine at codon 2353 is replaced by serine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001350891 | SCV002082632 | uncertain significance | Cohen syndrome | 2021-01-11 | no assertion criteria provided | clinical testing |